David Mamet didn’t write the dialogue in this $40 million court order. It just sounds that way.
David Mamet didn’t write the dialogue in this $40 million court order. It just sounds that way. Not much compares to the crackling dialogue of a David Mamet play.
David Mamet didn’t write the dialogue in this $40 million court order. It just sounds that way.
- Not much compares to the crackling dialogue of a David Mamet play.
- In addition to $15 million in redress, the court order banned unsubstantiated claims and required a health warning on products containing yohimbine, an evergreen derivative sold as an impotence treatment.
- That should have given any prudent marketer 15 million reasons to rethink their business practices, but that’s not what happened here.
- So the FTC returned to court, arguing that Hi-Tech Pharmaceuticals, Jared Wheat, and Steven Smith were in contempt of the injunction.
- (Merits of the case aside, we’re partial to the Maynard G. Krebs-like use of the word “cat” in this context.)
- Although Wheat claimed to have made a good faith effort, the Court found the argument unavailing.
- In addition, the Court cited a number of questionable transactions totaling in the multi-millions.